Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,436 | 85 | 73.7% |
| Travel and Lodging | $488.16 | 2 | 25.1% |
| Education | $23.64 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $488.16 | 2 | $0 (2019) |
| AbbVie Inc. | $335.20 | 22 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $280.25 | 17 | $0 (2023) |
| Gilead Sciences, Inc. | $234.81 | 18 | $0 (2020) |
| Intercept Pharmaceuticals, Inc. | $115.82 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $114.73 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $79.62 | 5 | $0 (2024) |
| UCB, Inc. | $47.08 | 3 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $43.75 | 3 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $38.38 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.91 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($44.25) |
| 2023 | $131.45 | 2 | E.R. Squibb & Sons, L.L.C. ($114.73) |
| 2020 | $134.07 | 9 | AbbVie Inc. ($45.93) |
| 2019 | $1,137 | 45 | Boston Scientific Corporation ($488.16) |
| 2018 | $300.11 | 20 | AbbVie, Inc. ($106.24) |
| 2017 | $177.89 | 11 | Valeant Pharmaceuticals North America LLC ($38.38) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Rare Disease | ||||||
| 08/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $44.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/10/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $114.73 | General |
| Category: Neuroscience | ||||||
| 03/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Gastroenterology | ||||||
| 03/17/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.60 | General |
| 02/27/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Immunology | ||||||
| 02/26/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/19/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: VIROLOGY | ||||||
| 02/14/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.10 | General |
| 01/21/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/20/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.15 | General |
| 12/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Motegrity (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Lower GI | ||||||
| 11/26/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Immunology | ||||||
| 11/21/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Motegrity (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: Lower GI | ||||||
| 11/11/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Virology | ||||||
| 11/07/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunology | ||||||
| 11/07/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Motegrity (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Lower GI | ||||||
| 11/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.47 | General |
| 10/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Motegrity (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Lower GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,103 | 1,211 | $614,369 | $112,273 |
| 2022 | 17 | 945 | 1,062 | $513,701 | $108,198 |
| 2021 | 16 | 910 | 998 | $522,465 | $105,805 |
| 2020 | 16 | 886 | 989 | $468,402 | $92,252 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 173 | 173 | $171,443 | $34,210 | 20.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 135 | 149 | $52,746 | $14,678 | 27.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 49 | 49 | $34,866 | $8,735 | 25.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 86 | 86 | $79,255 | $7,885 | 9.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 153 | 156 | $127,296 | $7,244 | 5.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 39 | 39 | $28,665 | $7,093 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 96 | $11,304 | $6,596 | 58.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 50 | 50 | $33,995 | $6,014 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 118 | $10,894 | $5,328 | 48.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 58 | 58 | $35,018 | $4,613 | 13.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $9,270 | $3,028 | 32.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 42 | $6,888 | $2,542 | 36.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 43 | $3,827 | $1,687 | 44.1% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Office | 2023 | 15 | 15 | $2,865 | $856.63 | 29.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $2,519 | $667.80 | 26.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $1,182 | $522.04 | 44.2% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 39 | 40 | $1,280 | $295.05 | 23.1% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 33 | 33 | $1,056 | $278.19 | 26.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 170 | 170 | $168,470 | $34,642 | 20.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 58 | 58 | $42,572 | $10,677 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 157 | $16,641 | $10,329 | 62.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 77 | 83 | $28,809 | $8,747 | 30.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 67 | 67 | $63,248 | $7,895 | 12.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 101 | 103 | $84,048 | $6,180 | 7.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 130 | $12,704 | $6,145 | 48.4% |
About Dr. William Simpson, M.D
Dr. William Simpson, M.D is a Gastroenterology healthcare provider based in Kalispell, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487655346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Simpson, M.D has received a total of $1,948 in payments from pharmaceutical and medical device companies, with $67.91 received in 2024. These payments were reported across 89 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,436).
As a Medicare-enrolled provider, Simpson has provided services to 3,844 Medicare beneficiaries, totaling 4,260 services with total Medicare billing of $418,528. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Kalispell, MT
- Active Since 08/02/2005
- Last Updated 11/27/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487655346
Products in Payments
- GENERAL POLYPECTOMY (Device) $488.16
- XIFAXAN (Drug) $235.02
- Mavyret (Drug) $156.85
- Humira (Biological) $132.42
- OCALIVA (Drug) $115.82
- ZEPOSIA (Drug) $114.73
- RELISTOR ORAL (Drug) $54.53
- Cimzia (Drug) $47.08
- EOHILIA (Drug) $44.25
- Trulance (Drug) $43.75
- Motegrity (Drug) $35.37
- HUMIRA (Biological) $34.93
- IQIRVO (Drug) $23.66
- Prolia (Biological) $22.22
- LIALDA (Drug) $20.24
- SAMSCA (Drug) $18.92
- Veltassa (Drug) $17.54
- CFN PleurX (Device) $17.44
- LINZESS (Drug) $14.28
- XELJANZ (Drug) $13.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Kalispell
Juergen Mueller, M.d, M.D
Gastroenterology — Payments: $3,242
Dr. Philip Jaffe, Md, MD
Gastroenterology — Payments: $1,240
Dr. Ramon Generoso, Md, MD
Gastroenterology — Payments: $654.17
Mrs. Jenna Grilley, Pa-C, PA-C
Gastroenterology — Payments: $212.79
Dr. Craig Harrison, Md, MD
Gastroenterology — Payments: $188.30
Dr. Howard Tice, Md, MD
Gastroenterology — Payments: $121.80